PMC-403
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PMC-403, covering 2025-12-30 to 2025-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration [Phase 1]